Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2025

Accounting Policies [Abstract]

Schedule of composition of net revenues by payor type and core service lines

The composition of net revenue by payor type for the years ended December 31, 2025, 2024 and 2023 are as follows (in thousands):

	Year Ended December 31,
	2025		2024		2023
Insurance	$	1,963,190	$	1,998,722	$	1,933,440
Government	852,988		842,552		852,789
Patient pay	428,679		419,701		413,948
Net revenue	$	3,244,857	$	3,260,975	$	3,200,177

The composition of net revenue by segment for the years ended December 31, 2025, 2024 and 2023 are as follows (in thousands):

	Year Ended December 31,
	2025		2024		2023
Net sales revenue:
Sleep Health	$	1,040,386	$	992,332	$	947,103
Respiratory Health	33,495		32,688		45,219
Diabetes Health	573,690		598,446		647,431
Wellness at Home	383,441		467,305		491,549
Total net sales revenue	$	2,031,012	$	2,090,771	$	2,131,302
Net revenue from fixed monthly equipment reimbursements:
Sleep Health	$	308,784	$	327,729	$	344,611
Respiratory Health	601,506		558,529		569,344
Diabetes Health	12,576		9,704		12,608
Wellness at Home	163,275		144,095		142,312
Total net revenue from fixed monthly equipment reimbursements	$	1,086,141	$	1,040,057	$	1,068,875
Net revenue from capitated revenue arrangements:
Sleep Health	$	28,977	$	29,152	$	—
Respiratory Health	56,159		59,933		—
Diabetes Health	6,147		6,260		—
Wellness at Home	36,421		34,802		—
Total net revenue from capitated revenue arrangements	$	127,704	$	130,147	$	—
Total net revenue:
Sleep Health	$	1,378,147	$	1,349,213	$	1,291,714
Respiratory Health	691,160		651,150		614,563
Diabetes Health	592,413		614,410		660,039
Wellness at Home	583,137		646,202		633,861
Total net revenue	$	3,244,857	$	3,260,975	$	3,200,177

Schedule of carrying amounts and estimated fair values of debt

The table below shows the carrying amounts and estimated fair values, net of unamortized deferred financing costs, of the Company’s long-term debt arrangements (in thousands):

	December 31, 2025				December 31, 2024
	Carrying Value		Fair Value		Carrying Value		Fair Value
Secured term loan	$	313,722	$	313,722	$	547,281	$	547,281
Senior unsecured notes	1,422,574		1,394,599		1,433,890		1,318,820
	$	1,736,296	$	1,708,321	$	1,981,171	$	1,866,101

Summary of useful lives of property and equipment for purposes of computing depreciation

The useful lives of property and equipment for purposes of computing depreciation are:

Patient medical equipment	13 months ‑ 5 years
Computers and software	5 ‑ 10 years
Delivery vehicles	5 years
Other	2 ‑ 10 years

Schedule of useful lives of intangible assets acquired

The following table summarizes the useful lives of the Company’s identifiable intangible assets:

Tradenames	5 to 10 years
Payor contracts	10 years

Summary of cost of net revenue

Cost of net revenue for the years ended December 31, 2025, 2024 and 2023 consisted of the following (in thousands):

	Year Ended December 31,
	2025		2024		2023
Cost of products and supplies	$	1,294,423	$	1,288,162	$	1,310,213
Salaries, labor and benefits	750,309		730,597		716,531
Patient equipment depreciation	341,287		320,289		325,696
Rent and occupancy	74,391		71,874		68,375
Other operating expenses	175,248		168,960		155,295
Total	$	2,635,658	$	2,579,882	$	2,576,110